Extracorporeal photopheresis treatment for steroid resistant graft versus host disease in pediatrics: single center experience
Yükleniyor...
Dosyalar
Tarih
2019
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Nature Publishing Group
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Background: Steroid resistant graft vs host disease (GVHD) is de?ned as unresolved or worsened symptomatology of GVHD at day 14 despite effective immunosuppression with steroid therapy. Second line immunosuppressive agents, extracorporeal photopheresis (ECP) and/or mesenchymal stem cell therapies are being tried as salvage therapy.
Açıklama
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) -- MAR 24-27, 2019 -- Frankfurt, GERMANY
Anahtar Kelimeler
Kaynak
Bone Marrow Transplantation
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
54
Sayı
Künye
Aksoy, B. A., Savci, Y. E., Mergen, A., Aydogdu, S., Dikme, G., Bozkurt, C., & Fisgin, T. (2019). Extracorporeal photopheresis treatment for steroid resistant graft versus host disease in pediatrics: Single center experience. BONE MARROW TRANSPLANTATION, 54(1), 195–196.
